What is the main business of PTG Network?

The main business activity of PTG Network focuses on other human health activities not elsewhere classified.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 7, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Inż. Pilota Wigury 19, 90-302 Łódź.

Who is on the management board?

The management board consists of: Barbara Kaczmarek (Member of the Management Board) and Robert Mordaka (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 75,000 (approx. $20,259).

What period do the latest financial data cover?

The latest available financial statement covers the period from November 7, 2023 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $9,020.

Is the company profitable?

No, in 2024 the company reported a net loss of $7,644.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $7,553 in 2024, representing 46% of all operating expenses.

PTG Networksp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-11-07

Share capital

75,000.00 PLN

Activity description

PTG Network connects sponsors, CROs, clinical sites and investigators in a Polish clinical trial network. It assesses the feasibility of Phase I–III trials, selects locations and builds research teams, conducting studies in fields including allergy, hepatology, dermatology, diabetes, gastroenterology and hematology.

Registered address

ul. Inż. Pilota Wigury 19, 90-302 Łódź, Poland

Website

ptg-network.com

Phone

Electronic delivery address

AE:PL-81096-54759-JFTSF-24

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 4 days early.

202510/07/2026
202412/07/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 11.55kMedianUSD 91.87kAverageUSD 1.38m

Net profit

This companyUSD 4.77kMedianUSD 2.66kAverageUSD 145.77k

Operating costs

This companyUSD 6.72kMedianUSD 82.72kAverageUSD 1.18m

Assets

This companyUSD 17.68kMedianUSD 39.38kAverageUSD 949.95k

Industry

Other human health activities not elsewhere classified (86.90.E)Primary

Offer

Clinical trials
Clinical trial organization
Clinical site selection
Patient recruitment
Research teams
Sponsor consultancy

Clients and partners

Instytut Msfsp. z o.o.

Authorized Representatives

Barbara Kaczmarek – Management Board Member

Robert Mordaka – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Barbara Kaczmarekage 59	75	$10,129.66	50%
Robert Mordakaage 60	75	$10,129.66	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-08-01.

ING Bank Śląski
04 1050 1012 1000 0090 8305 2887
ING Bank Śląski
26 1050 1012 1000 0090 8305 2879

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Centrum Badań Medycznych Brand Medsp. z o.o.	$66,160.01	brand-med.pl
TMRWsp. z o.o.	$55,483.98	tomorrowlabs.pl
PRO Medica Herbabetsp. z o.o.	$54,490.71	promedicaherbabet.pl
Poliklinika Śremsp. z o.o.	$36,959.88	poliklinikasrem.pl
ETG Centrum Medycznesp. z o.o.	$34,334.57	etgcentrummedyczne.pl
Info-Patsp. z o.o.	$10,464.59	info-pat.poznan.pl
Optitrialsp. z o.o.	$8,036.16	optitrial.eu

FAQ

Last updated: 2026-07-13